Interatrial communication

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1478OMIM:108800Q21.1
Who is this for?
Show terms as
1FDA treatments7Active trials63Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Interatrial communication, commonly known as atrial septal defect (ASD), is a congenital heart defect characterized by an abnormal opening in the septum (wall) that separates the two upper chambers (atria) of the heart. This opening allows oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium, resulting in a left-to-right shunt that increases blood flow to the lungs. There are several types of ASD, including ostium secundum (the most common, located in the central portion of the septum), ostium primum (located in the lower part of the septum, often associated with atrioventricular valve abnormalities), sinus venosus (located near the entry of the superior or inferior vena cava), and coronary sinus defects. Many individuals with small ASDs are asymptomatic in childhood, and the defect may not be detected until adulthood. When symptoms do occur, they can include fatigue, shortness of breath (especially during exercise), frequent respiratory infections, heart palpitations, and poor growth in children. If left untreated, a significant ASD can lead to serious complications over time, including right heart enlargement, pulmonary hypertension, atrial arrhythmias (such as atrial fibrillation or flutter), heart failure, and in rare cases, paradoxical embolism leading to stroke. Treatment depends on the size and type of the defect and the presence of symptoms. Small ASDs may close spontaneously during childhood and require only monitoring. Larger or hemodynamically significant defects typically require closure, which can be achieved through percutaneous transcatheter device closure (for suitable secundum-type defects) or open-heart surgical repair. Early intervention generally carries an excellent prognosis. Patients with repaired ASDs usually have a normal or near-normal life expectancy, though long-term follow-up is recommended to monitor for arrhythmias or residual shunting.

Also known as:

Clinical phenotype terms— hover any for plain English:

Secundum atrial septal defectHP:0001684Atrial fibrillationHP:0005110Systolic heart murmurHP:0031664Atrial flutterHP:0004749Right ventricular dilatationHP:0005133Primum atrial septal defectHP:0010445Sinus venosus atrial septal defectHP:0011567Complete right bundle branch blockHP:0011712Right axis deviationHP:0033567Coronary sinus atrial septal defectHP:0011643
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Sep 2026Transdiagnostic Sleep and Circadian Treatment for Autistic Adults

Milton S. Hershey Medical Center — NA

TrialNOT YET RECRUITING
Aug 2026Buspirone for Anxiety in Autistic Youth

Massachusetts General Hospital — PHASE4

TrialNOT YET RECRUITING
Jul 2026NTI164 in Autism Spectrum Disorder

Fenix Innovation Group — PHASE3

TrialNOT YET RECRUITING
Jun 2026Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families

The University of Texas Health Science Center, Houston — NA

TrialNOT YET RECRUITING
Apr 2026Transcranial Direct Current Stimulation in Children With Autism

New York State Institute for Basic Research — NA

TrialRECRUITING
Apr 2026TF-CBT for Autistic Youth Pilot Implementation - Open Pilot

Dartmouth-Hitchcock Medical Center — NA

TrialRECRUITING
Apr 2026Differences in Rest, Emotion, and Arousal Modulation in Youth

University of Pittsburgh — NA

TrialNOT YET RECRUITING
Apr 2026Family-Centered Implementation of Parent Training for Autistic Toddlers in Early Intervention

University of South Carolina — NA

TrialNOT YET RECRUITING
Apr 2026Improving Caregiver Engagement in Early Interventions

University of California, Davis — NA

TrialNOT YET RECRUITING
Mar 2026A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively

Karuna Therapeutics, Inc., a Bristol Myers Squibb company — PHASE3

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE· Sun Pharmaceuticals Industries, Inc.
Sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. Administer dexmedetomidine hydrochloride by continuous infusion not to exceed

Sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. Administer dexmedetomidine hydrochloride by continuous infusion not to exceed 24 hours.

Clinical Trials

7 recruitingView all trials with filters →
Phase 41 trial
Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect
Phase 4
Actively Recruiting
· Sites: Alexandria, Alexandria Governorate · Age: 312 yrs
N/A1 trial
Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect
N/A
Actively Recruiting
PI: Jong-Min Song, MD PhD (Asan Medical Center) · Sites: Seoul · Age: 1880 yrs
Other5 trials
Abbott Structural Heart Device Registry
Actively Recruiting
PI: Ryan Palmer (Abbott) · Sites: New Brunswick, New Jersey; New York, New York +25 more
Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study
Actively Recruiting
· Sites: Ankara; Diyarbakır +3 more
Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up
Actively Recruiting
· Sites: Curitiba; Fortaleza +5 more
Cera™ ASD Occluder Post-Market Clinical Follow-Up Study
Actively Recruiting
· Sites: Myszków; Oświęcim +4 more
Cerebral Microembolization Associated With PFO Closure
Actively Recruiting
PI: Chaowu Yan, PhD MD (Cardiovascular Institute and Fuwai Hospital) · Sites: Beijing, Beijing Municipality · Age: 1865 yrs

Specialists

Showing 25 of 63View all specialists →
AM
Alexander Kolevzon, MD
NEW YORK, NY
Specialist
PI on 11 active trials1 Interatrial communication publication
FM
Forbes D Porter, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 14 active trials
LM
Logan K Wink, MD
CINCINNATI, OH
Specialist
PI on 2 active trials1 Interatrial communication publication
JM
Joanne Kurtzberg, MD
DURHAM, NC
Specialist
PI on 11 active trials
CM
Chadwick Prodromos, MD
GLENVIEW, IL
Specialist
PI on 11 active trials
AM
Athena Zuppa, MD, MSCE
PHILADELPHIA, PA
Specialist
PI on 2 active trials
EM
Eric Hollander, MD
Specialist
PI on 5 active trials
KM
Katherine France, DMD, MBE
Specialist
PI on 2 active trials
AP
Andrew Lovering, PhD
Specialist
PI on 2 active trials
AA
Areej AA Tammam Alkhateeb
Specialist
PI on 1 active trial
JH
Jan Henzel
Specialist
PI on 1 active trial
BS
Barathi Sethuraman
Specialist
PI on 1 active trial
ZK
Zarmiga Karunanithi
Specialist
PI on 1 active trial
JS
Jong-Min Song
Specialist
PI on 1 active trial
IJ
Ida Jovanovic
Specialist
PI on 1 active trial
RS
Robert Sommer
NEW YORK, NY
Specialist
PI on 1 active trial
IC
Iksung Cho
Specialist
PI on 1 active trial
RS
Raghda El sheikh
Specialist
PI on 1 active trial
AO
Ashish Oza
Specialist
PI on 1 active trial
AK
Aditya K Kaza
BOSTON, MA
Specialist
PI on 2 active trials
HS
Heroe Soebroto
Specialist
PI on 1 active trial
XP
Xiangbin Pan
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
DEXMEDETOMIDINE HYDROCHLORIDE(DEXMEDETOMIDINE HYDROCHLORIDE)Sun Pharmaceuticals Industries, Inc.

Travel Grants

No travel grants are currently matched to Interatrial communication.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Interatrial communicationForum →

No community posts yet. Be the first to share your experience with Interatrial communication.

Start the conversation →

Latest news about Interatrial communication

Disease timeline:

New recruiting trial: Russian Registry of Endovascular Closure of PFO

A new clinical trial is recruiting patients for Interatrial communication

New recruiting trial: Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale

A new clinical trial is recruiting patients for Interatrial communication

New recruiting trial: A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine

A new clinical trial is recruiting patients for Interatrial communication

New recruiting trial: Standardized Goal-Directed vs. Self-Directed Valsalva Maneuver for the Assessment of Patent Foramen Ovale

A new clinical trial is recruiting patients for Interatrial communication

New recruiting trial: SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation

A new clinical trial is recruiting patients for Interatrial communication

New recruiting trial: CeraFlex PFO Closure System PMCF Study

A new clinical trial is recruiting patients for Interatrial communication

New recruiting trial: Swartz Sheath With Angioplasty Guidewire-Assisted Technique for Patent Foramen Ovale Closure (STAGE-PFO)

A new clinical trial is recruiting patients for Interatrial communication

New recruiting trial: Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study

A new clinical trial is recruiting patients for Interatrial communication

New recruiting trial: Cerebral Microembolization Associated With PFO Closure

A new clinical trial is recruiting patients for Interatrial communication

New recruiting trial: Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

A new clinical trial is recruiting patients for Interatrial communication

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Interatrial communication

What is Interatrial communication?

Interatrial communication, commonly known as atrial septal defect (ASD), is a congenital heart defect characterized by an abnormal opening in the septum (wall) that separates the two upper chambers (atria) of the heart. This opening allows oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium, resulting in a left-to-right shunt that increases blood flow to the lungs. There are several types of ASD, including ostium secundum (the most common, located in the central portion of the septum), ostium primum (located in the lower part of the septum, often associated

Are there clinical trials for Interatrial communication?

Yes — 7 recruiting clinical trials are currently listed for Interatrial communication on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Interatrial communication?

25 specialists and care centers treating Interatrial communication are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.